Hanjin Shipping Upsets Global Trade After Seeking Protection From Creditors

Related Link: 

South Korea’s Hanjin Shipping Co., one of the world’s largest shipping lines, stopped taking new cargo, and U.S. ports began turning away its ships after it filed for bankruptcy protection in Seoul.

The ECB's Persistent Inflation Headache

Related Link: 

Eurozone inflation remains stuck in low gear. Expectations are building again for more from the ECB.

Samsung Introduces New Gear S3 Smartwatch

Related Link: 

Samsung Electronics Co., Ltd. unveiled its new Gear S3 smartwatch ahead of the IFA consumer electronics trade fair in Berlin.

Move by South Korea's Hanjin Roils Global Shipping

Related Link: 

U.S. shippers say they are bracing for steep rate increases out of Asia after South Korea’s Hanjin Shipping Co. filed for receivership.

It's Time to Sweat Again at Lululemon

Related Link: 

The yoga-wear maker’s shares have rallied by more than one-third this year. Additional gains might be a stretch.

French Carrier Orange Pursues Stake in Iranian Wireless Firm

Related Link: 

French wireless carrier Orange is in preliminary talks to buy a stake in Iran’s largest cellular operator, Mobile Telecommunication Co. of Iran, discussions that point up the promise and perils of investment in the Islamic republic.

Insurers Move to Limit Options in Health-Care Exchange Plans

Related Link: 

Under intense pressure to curb costs that have led to losses on the Affordable Care Act exchanges, insurers are accelerating their move toward plans that offer limited choices of doctors and hospitals.

Finding Safer Ground at Palo Alto Networks

Related Link: 

A rich multiple has made cybersecurity star Palo Alto Networks a dangerous play, but its shifting revenue mix is a good sign.

Personal-Privacy Concerns Grip China

Related Link: 

Columnist Li Yuan writes that national outrage in China over reports of a phone swindle is focusing new attention on lax privacy protections.

Bidding War for Medivation Is Good News for Biotech

Related Link: 

Pfizer had stiff competition in the chase for Medivation, which bodes well for biotech.

Syndicate content